<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39371439</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2732-494X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Antimicrobial stewardship &amp; healthcare epidemiology : ASHE</Title><ISOAbbreviation>Antimicrob Steward Healthc Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Trends in antibiotic utilization for patients hospitalized with COVID-19 with and without signs of sepsis.</ArticleTitle><Pagination><StartPage>e143</StartPage><MedlinePgn>e143</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e143</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/ash.2024.366</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To assess trends in antibiotic prescribing for patients hospitalized with COVID-19 with and without sepsis.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">Retrospective cohort study using electronic health record (EHR) data.</AbstractText><AbstractText Label="SETTING" NlmCategory="UNASSIGNED">Five hospitals in eastern Massachusetts.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="UNASSIGNED">Adults (≥18 years) hospitalized with community-onset SARS-CoV-2 infections between March 2020 and November 2022.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We assessed quarterly trends in the use of prolonged initial antibiotic therapy (≥4 antibiotic days within one week of admission, including discharge antibiotics) amongst COVID-19 patients with and without sepsis, defined using clinical signs of organ dysfunction before hospital day 3. Poisson regression models were used to adjust for baseline characteristics and severity of illness.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of 431,017 hospitalizations in the study period, 21,563 (5.0%) had community-onset COVID-19. 4,769/21,563 (20.5%) presented with sepsis. Prolonged antibiotics were prescribed in 2,323/4,769 (48.7%) COVID-19 patients with sepsis and 2,866/16,794 (17.1%) without sepsis despite low rates of positive bacterial cultures on admission (15.0% vs 6.3%, respectively). Quarterly rates of prolonged antibiotics declined between the first and second pandemic quarters for both sepsis (66.8% to 43.9%) and no-sepsis (31.8% to 24.4%) groups. However, there was no significant change thereafter through November 2022 in either group (quarterly aORs 1.02, 95% CI 0.99-1.05 and 1.01, 95% CI 0.99-1.03, respectively).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Prolonged antibiotics were common in hospitalized COVID-19 patients with and without sepsis during the first 33 months of the pandemic despite low rates of proven bacterial infection. Decreases in antibiotic utilization occurred primarily between the first and second pandemic quarter with no further reduction thereafter.</AbstractText><CopyrightInformation>© The Author(s) 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shappell</LastName><ForeName>Claire N</ForeName><Initials>CN</Initials><Identifier Source="ORCID">0000-0002-8316-1496</Identifier><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klompas</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8641-4498</Identifier><AffiliationInfo><Affiliation>Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Christina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0028-3808</Identifier><AffiliationInfo><Affiliation>Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Tom</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-5301-5447</Identifier><AffiliationInfo><Affiliation>Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhee</LastName><ForeName>Chanu</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-9537-4245</Identifier><AffiliationInfo><Affiliation>Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Antimicrob Steward Healthc Epidemiol</MedlineTA><NlmUniqueID>9918266096106676</NlmUniqueID><ISSNLinking>2732-494X</ISSNLinking></MedlineJournalInfo><CoiStatement>Dr Klompas reports personal fees from UpToDate outside the submitted work. Dr Rhee reports personal fees from UpToDate and Cytovale outside the submitted work. No other potential conflicts of interest relevant to the submitted work were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>11</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39371439</ArticleId><ArticleId IdType="pmc">PMC11450668</ArticleId><ArticleId IdType="doi">10.1017/ash.2024.366</ArticleId><ArticleId IdType="pii">S2732494X24003668</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 2016;315:801–10. doi: 10.1001/jama.2016.0287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250–6. doi: 10.1097/01.CCM.0000050454.01978.3B</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000050454.01978.3B</ArticleId><ArticleId IdType="pubmed">12682500</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644–55. doi: 10.1378/chest.101.6.1644</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.101.6.1644</ArticleId><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Karakike E, Giamarellos-Bourboulis EJ, Kyprianou M, et al. Coronavirus disease 2019 as cause of viral sepsis: a systematic review and meta-analysis. Crit Care Med 2021;49:2042–2057. doi: 10.1097/CCM.0000000000005195</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005195</ArticleId><ArticleId IdType="pmc">PMC8594513</ArticleId><ArticleId IdType="pubmed">34259663</ArticleId></ArticleIdList></Reference><Reference><Citation>Shappell C, Rhee C, Klompas M. Update on sepsis epidemiology in the era of COVID-19. Semin Respir Crit Care Med 2023;44:173–184. doi: 10.1055/s-0042-1759880</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1759880</ArticleId><ArticleId IdType="pubmed">36646093</ArticleId></ArticleIdList></Reference><Reference><Citation>Shappell CN, Klompas M, Chan C, et al. Use of electronic clinical data to track incidence and mortality for SARS-CoV-2-associated sepsis. JAMA Netw Open 2023;6:e2335728. doi: 10.1001/jamanetworkopen.2023.35728</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.35728</ArticleId><ArticleId IdType="pmc">PMC10543118</ArticleId><ArticleId IdType="pubmed">37773495</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017;43:304–377. doi: 10.1007/s00134-017-4683-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4683-6</ArticleId><ArticleId IdType="pubmed">28101605</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn VM, Gandhi TN, Petty LA, et al. Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with coronavirus disease 2019 (COVID-19): A multi-hospital cohort study. Clin Infect Dis 2021;72:e533–e541. doi: 10.1093/cid/ciaa1239</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1239</ArticleId><ArticleId IdType="pmc">PMC7499526</ArticleId><ArticleId IdType="pubmed">32820807</ArticleId></ArticleIdList></Reference><Reference><Citation>Elligsen M, Wan M, Lam PW, et al. Trends in hospital antibiotic utilization during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter interrupted time-series analysis. Antimicrob Steward Healthc Epidemiol 2022;2:e128. doi: 10.1017/ash.2022.268</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ash.2022.268</ArticleId><ArticleId IdType="pmc">PMC9726493</ArticleId><ArticleId IdType="pubmed">36483375</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C, Wolford H, Baggs J, et al. Antibiotic use among hospitalized patients with COVID-19 in the United States, March 2020-June 2022. Open Forum Infect Dis 2023;10:ofad503. doi: 10.1093/ofid/ofad503</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad503</ArticleId><ArticleId IdType="pmc">PMC10629359</ArticleId><ArticleId IdType="pubmed">37942462</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Baker MA, Kanjilal S, et al. Prospective clinical assessments of hospitalized patients with positive SARS-CoV-2 PCR tests for necessity of isolation. Open Forum Infect Dis 2021;8:ofab194. doi: 10.1093/ofid/ofab194</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab194</ArticleId><ArticleId IdType="pmc">PMC8083210</ArticleId><ArticleId IdType="pubmed">34316502</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Kadri SS, Dekker JP, et al. Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open 2020;3:e202899. doi: 10.1001/jamanetworkopen.2020.2899</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.2899</ArticleId><ArticleId IdType="pmc">PMC7163409</ArticleId><ArticleId IdType="pubmed">32297949</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>